thymoquinone has been researched along with Kahler Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, KS; Chng, WJ; Kannaiyan, R; Kumar, AP; Li, F; Mustafa, N; Sethi, G; Siveen, KS | 1 |
| Li, F; Rajendran, P; Sethi, G | 1 |
| Badr, G; Lefevre, EA; Mohany, M | 1 |
| Abu-Tarboush, F; Badr, G; Mohany, M | 1 |
4 other study(ies) available for thymoquinone and Kahler Disease
| Article | Year |
|---|---|
Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-κB regulated gene products in multiple myeloma xenograft mouse model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzoquinones; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Synergism; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Multiple Myeloma; NF-kappa B; Pyrazines; Random Allocation; Signal Transduction; Xenograft Model Antitumor Assays | 2014 |
Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway.
Topics: Antineoplastic Agents; Apoptosis; Benzoquinones; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Humans; Inositol Polyphosphate 5-Phosphatases; Interleukin-6; Janus Kinase 2; Multiple Myeloma; Phosphoric Monoester Hydrolases; Phosphorylation; Pyrazines; Signal Transduction; STAT3 Transcription Factor; Thalidomide; Vanadates | 2010 |
Thymoquinone inhibits the CXCL12-induced chemotaxis of multiple myeloma cells and increases their susceptibility to Fas-mediated apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Benzoquinones; Cell Line, Tumor; Cell Survival; Chemokine CXCL12; Chemotaxis; Dose-Response Relationship, Drug; Enzyme Activation; fas Receptor; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Kinase; Leukocyte Common Antigens; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Multiple Myeloma; NF-kappa B; Phosphatidylinositol 3-Kinases; Phospholipase C beta; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptors, CXCR4; rhoA GTP-Binding Protein; Time Factors | 2011 |
Thymoquinone decreases F-actin polymerization and the proliferation of human multiple myeloma cells by suppressing STAT3 phosphorylation and Bcl2/Bcl-XL expression.
Topics: Actins; Antineoplastic Agents; bcl-X Protein; Benzoquinones; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemokine CXCL12; Gene Expression; Humans; Interleukin-6; Multiple Myeloma; Phosphorylation; Protein Multimerization; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-bcl-2; STAT3 Transcription Factor; STAT5 Transcription Factor | 2011 |